gen_bio_logo (1)

The Generative Biology Revolution - A special 4-part podcast series

Welcome to The Generative Biology Revolution, a special edition podcast series produced by The Scientist’s Creative Services Team.

This series is brought to you by Amgen, a pioneer in the science of using living cells to make biologic medicines. They helped invent the processes and tools that built the global biotech industry, and have since reached millions of patients suffering from serious illnesses around the world with their medicines.

Generative biology is a revolutionary approach to drug discovery and development that leverages machine learning and AI to design novel protein therapeutics. It holds the potential to enhance the speed and efficiency of discovery. In this series, Ray Deshaies, senior vice president of Global Research at Amgen, discusses how generative biology is transforming drug discovery to make it more predictable, shorten timelines, and increase success rates of bringing life-saving medicines to patients who need them most.

Sign up now to receive an email when each podcast episode airs.
  • Episode 1 - The Cresting Wave of Transformational Science
    June 23, 2022
  • Episode 2 - The Protein Structure Prediction Problem
    June 30, 2022
  • Episode 3 - Protein Design from Scratch
    July 7, 2022
  • Episode 4 - Accelerating Drug Discovery with Protein Design
    July 14, 2022
Visit this page to sign up for the Generative Biology Revolution Q&A event, airing soon!
  • Webinar - The Generative Biology Revolution
    July 20, 2022 @ 2:30 PM ET




Ray Deshaies, PhD
Senior Vice President
Global Research



Sign up and listen now

TS_Podcast_Amgen_Series 1_Generative Biology Revolution_IO#14829

Information you provide will be held in confidence and will be shared with the sponsoring vendor(s) of these podcasts. We may use the information to contact you about your account and to let you know about related programs and products; you may opt-out at any time. This allows The Scientist to keep these podcasts free of charge for our readers.